BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25071010)

  • 21. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC).
    Bunch B; Krishnan N; Greenspan RD; Ramakrishnan S; Attwood K; Yan L; Qi Q; Wang D; Morrison C; Omilian A; Bshara W; Pili R; Trump DL; Johnson C; Woloszynska A
    Cell Cycle; 2019 Sep; 18(17):2055-2066. PubMed ID: 31318640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
    Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
    J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.
    Benosman S; Meng X; Von Grabowiecki Y; Palamiuc L; Hritcu L; Gross I; Mellitzer G; Taya Y; Loeffler JP; Gaiddon C
    J Biol Chem; 2011 Dec; 286(50):43013-25. PubMed ID: 22002055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p73 induces apoptosis by different mechanisms.
    Ramadan S; Terrinoni A; Catani MV; Sayan AE; Knight RA; Mueller M; Krammer PH; Melino G; Candi E
    Biochem Biophys Res Commun; 2005 Jun; 331(3):713-7. PubMed ID: 15865927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of methylation in the control of DeltaNp73 expression in neuroblastoma.
    Casciano I; Banelli B; Croce M; Allemanni G; Ferrini S; Tonini GP; Ponzoni M; Romani M
    Cell Death Differ; 2002 Mar; 9(3):343-5. PubMed ID: 11859417
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors.
    Vilgelm AE; Hong SM; Washington MK; Wei J; Chen H; El-Rifai W; Zaika A
    Oncogene; 2010 Oct; 29(43):5861-8. PubMed ID: 20676143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of TAP73 and DeltaNP73 in malignant gliomas.
    Ugur H; Sayan AE; Ozdamar SO; Kanpolat Y; Ozturk M
    Oncol Rep; 2004 Jun; 11(6):1337-41. PubMed ID: 15138575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammary epithelial cell polarity is regulated differentially by p73 isoforms via epithelial-to-mesenchymal transition.
    Zhang Y; Yan W; Jung YS; Chen X
    J Biol Chem; 2012 May; 287(21):17746-17753. PubMed ID: 22457351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DeltaNp73 transcription factors modulate cell survival and tumor development.
    Ravni A; Tissir F; Goffinet AM
    Cell Cycle; 2010 Apr; 9(8):1523-7. PubMed ID: 20372082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literature.
    Hofstetter G; Berger A; Chamson M; Müller-Holzner E; Reimer D; Ulmer H; Uramoto H; Marth C; Zeimet AG; Zeillinger R; Concin N
    Int J Gynecol Pathol; 2011 Nov; 30(6):527-31. PubMed ID: 21979586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.
    Vayssade M; Haddada H; Faridoni-Laurens L; Tourpin S; Valent A; Bénard J; Ahomadegbe JC
    Int J Cancer; 2005 Oct; 116(6):860-9. PubMed ID: 15849742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma.
    Ibrahim N; He L; Leong CO; Xing D; Karlan BY; Swisher EM; Rueda BR; Orsulic S; Ellisen LW
    Cancer Res; 2010 Sep; 70(18):7155-65. PubMed ID: 20807817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple isoforms of the tumor protein p73 are expressed in the adult human telencephalon and choroid plexus and present in the cerebrospinal fluid.
    Cabrera-Socorro A; Pueyo Morlans M; Suarez Sola ML; Gonzalez Delgado FJ; Castañeyra-Perdomo A; Marin MC; Meyer G
    Eur J Neurosci; 2006 Apr; 23(8):2109-18. PubMed ID: 16630058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activity.
    Stantic M; Sakil HA; Zirath H; Fang T; Sanz G; Fernandez-Woodbridge A; Marin A; Susanto E; Mak TW; Arsenian Henriksson M; Wilhelm MT
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):220-5. PubMed ID: 25535357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth.
    Subramanian D; Bunjobpol W; Sabapathy K
    J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival.
    Zitterbart K; Zavrelova I; Kadlecova J; Spesna R; Kratochvilova A; Pavelka Z; Sterba J
    Acta Neuropathol; 2007 Dec; 114(6):641-50. PubMed ID: 17912537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of WWOX alterations on p73, ΔNp73, p53, cell proliferation and DNA ploidy in salivary gland neoplasms.
    Gomes CC; Diniz MG; Oliveira CS; Tavassoli M; Odell EW; Gomez RS; De Marco L
    Oral Dis; 2011 Sep; 17(6):564-71. PubMed ID: 21332605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.